3,083
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease

, , , , , ORCID Icon & show all
Pages 580-593 | Received 02 Jan 2021, Accepted 23 Feb 2021, Published online: 17 Mar 2021

References

  • Abbas Z, Soomro R, Kalwar N, et al. (2019). In situ growth of CuWO nanospheres over graphene oxide for photoelectrochemical (PEC) immunosensing of clinical biomarker. Sensors (Basel, Switzerland) 20:148.
  • Bahman F, Greish K, Taurin S. (2019). Nanotechnology in insulin delivery for management of diabetes. Pharm Nanotechnol 7:113–28.
  • Buskaran K, Hussein M, Mohd Moklas M, et al. (2020). Morphological changes and cellular uptake of functionalized graphene oxide loaded with protocatechuic acid and folic acid in hepatocellular carcinoma cancer cell. Int J Mol Sci 21:5874.
  • Butterfield D, Boyd-Kimball D. (2018). Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer's disease. J Alzheimers Dis 62:1345–67.
  • Butterfield DA, Swomley AM, Sultana R. (2013). Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal 19:823–35.
  • Chakraborty S, Bandyopadhyay J, Chakraborty S, et al. (2016). Multi-target screening mines hesperidin as a multi-potent inhibitor: implication in Alzheimer's disease therapeutics. Eur J Med Chem 121:810–22.
  • Chalansonnet M, Carabin N, Boucard S, et al. (2018). Study of potential transfer of aluminum to the brain via the olfactory pathway. Toxicol Lett 283:77–85.
  • Cheng F, Ma C, Sun L, et al. (2018). Synergistic neuroprotective effects of geniposide and ursodeoxycholic acid in hypoxia-reoxygenation injury in SH-SY5Y cells. Exp Ther Med 15:320–6.
  • Cui L, Cai Y, Cheng W, et al. (2017). A novel, multi-target natural drug candidate, matrine, improves cognitive deficits in Alzheimer's disease transgenic mice by inhibiting Aβ aggregation and blocking the RAGE/Aβ axis. Mol Neurobiol 54:1939–52.
  • Datta L, Samanta S, Govindaraju T. (2020). Polyampholyte-based synthetic chaperone modulate amyloid aggregation and lithium delivery. ACS Chem Neurosci 11:2812–26.
  • Espinoza L, Silva-Abreu M, Clares B, et al. (2019). Formulation strategies to improve nose-to-brain delivery of donepezil. Pharmaceutics 11:64.
  • Fransquet P, Lacaze P, Saffery R, et al. (2018). Blood DNA methylation as a potential biomarker of dementia: a systematic review. Alzheimers Dement 14:81–103.
  • He Z, Li J, Chen S, et al. (2019). Surface inhomogeneity of graphene oxide influences dissociation of Aβ16-21 peptide assembly. J Phys Chem B 123:9098–103.
  • Henrich-Noack P, Nikitovic D, Neagu M, et al. (2019). The blood–brain barrier and beyond: nano-based neuropharmacology and the role of extracellular matrix. Nanomedicine 17:359–79.
  • Jansook P, Pichayakorn W, Ritthidej G. (2018). Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations. Drug Dev Ind Pharm 44:1693–700.
  • Kamei N, Okada N, Ikeda T, et al. (2018). Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction. Sci Rep 8:17641.
  • Langen U, Ayloo S, Gu C. (2019). Development and cell biology of the blood–brain barrier. Annu Rev Cell Dev Biol 35:591–613.
  • Li X, Li K, Chu F, et al. (2020). Graphene oxide enhances β-amyloid clearance by inducing autophagy of microglia and neurons. Chem Biol Interact 325:109126.
  • Li X, Run X, Wei Z, et al. (2019). Intranasal insulin prevents anesthesia-induced cognitive impairments in aged mice. Curr Alzheimer Res 16:8–18.
  • Li YH, Gong PL. (2007). Neuroprotective effects of dauricine against apoptosis induced by transient focal cerebral ischaemia in rats via a mitochondrial pathway. Clin Exp Pharmacol Physiol 34:177–84.
  • Liu C, Xie H, Yu J, et al. (2018). A targeted therapy for melanoma by graphene oxide composite with microRNA carrier. Drug Des Devel Ther 12:3095–106.
  • Liu L, Liu J. (2016). A strategy for quality control of Menispermum dauricum DC based on cytotoxic activity and HPLC fingerprint analysis. Indian J Pharm Sci 78:143–50.
  • Lv H, Wu C, Liu X, et al. (2018). Folate-functionalized mesoporous hollow SnO2 nanofibers as a targeting drug carrier to improve the antitumor effect of paclitaxel for liver cancer therapy. Biomed Res Int 2018:8526190.
  • Maciel E, Mejía-Carmona K, Jordan-Sinisterra M, et al. (2020). The current role of graphene-based nanomaterials in the sample preparation arena. Front Chem 8:664.
  • Moorthy H, Govindaraju T. (2021). Dendrimer architectonics to treat cancer and neurodegenerative diseases with implications in theranostics and personalized medicine. ACS Appl Bio Mater 4:1115–39.
  • Pandurangan K, Roy B, Rajasekhar K, et al. (2020). Molecular architectonics of cyclic dipeptide amphiphiles and their application in drug delivery. ACS Appl Bio Mater 3:3413–22.
  • Parviz D, Strano M. (2018). Endotoxin-free preparation of graphene oxide and graphene-based materials for biological applications. Curr Protoc Chem Biol 10:e51.
  • Pu Z, Ma S, Wang L, et al. (2018). Amyloid-beta degradation and neuroprotection of dauricine mediated by unfolded protein response in a Caenorhabditis elegans model of Alzheimer's disease. Neuroscience 392:25–37.
  • Rajasekhar K, Chakrabarti M, Govindaraju T. (2015). Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease. Chem Commun (Camb) 51:13434–50.
  • Rajasekhar K, Govindaraju T. (2018). Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease. RSC Adv 8:23780–804.
  • Rajasekhar K, Mehta K, Govindaraju T. (2018). Hybrid multifunctional modulators inhibit multifaceted Aβ toxicity and prevent mitochondrial damage. ACS Chem Neurosci 9:1432–40.
  • Rajasekhar K, Samanta S, Bagoband V, et al. (2020). Antioxidant berberine-derivative inhibits multifaceted amyloid toxicity. iScience 23:101005.
  • Rohrer J, Lupo N, Bernkop-Schnürch A. (2018). Advanced formulations for intranasal delivery of biologics. Int J Pharm 553:8–20.
  • Rojo A, Pajares M, Rada P, et al. (2017). NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology. Redox Biol 13:444–51.
  • Samanta S, Rajasekhar K, Babagond V, et al. (2019). Small molecule inhibits metal-dependent and -independent multifaceted toxicity of Alzheimer's disease. ACS Chem Neurosci 10:3611–21.
  • Sarkar A, Fatima I, Jamal Q, et al. (2017). Nanoparticles as a carrier system for drug delivery across blood brain barrier. Curr Drug Metab 18:129–37.
  • Serralheiro A, Alves G, Fortuna A, et al. (2014). Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting. Eur J Pharm Sci 60:32–9.
  • Sun X, Zebibula A, Dong X, et al. (2018). Aggregation-induced emission nanoparticles encapsulated with PEGylated nano graphene oxide and their applications in two-photon fluorescence bioimaging and photodynamic therapy in vitro and in vivo. ACS Appl Mater Interfaces 10:25037–46.
  • Tiozzo Fasiolo L, Manniello M, Bortolotti F, et al. (2019). Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer's disease. J Drug Target 27:984–94.
  • Uzun S, Kozumplik O, Folnegović-Smalc V. (2011). Alzheimer's dementia: current data review. Coll Antropol 35:1333–7.
  • Wang J, Zhai W, Yu Z, et al. (2017). Neuroprotection exerted by Netrin-1 and kinesin motor KIF1A in secondary brain injury following experimental intracerebral hemorrhage in rats. Front Cell Neurosci 11:432.
  • Wang L, Pu Z, Li M, et al. (2020). Antioxidative and antiapoptosis: neuroprotective effects of dauricine in Alzheimer's disease models. Life Sci 243:117237.
  • Wei J, Fang L, Liang X, et al. (2015). A sensitive and selective UPLC–MS/MS method for simultaneous determination of 10 alkaloids from Rhizoma Menispermi in rat plasma and its application to a pharmacokinetic study. Talanta 144:662–70.
  • Xia J, Zhu Y, He Z, et al. (2019). Superstrong noncovalent interface between melamine and graphene oxide. ACS Appl Mater Interfaces 11:17068–78.
  • Xiao H, Jensen P, Chen X. (2019). Elimination of osteosarcoma by necroptosis with graphene oxide-associated anti-HER2 antibodies. Int J Mol Sci 20:4360.
  • Xie M, Zhang G, Yin W, et al. (2018). Cognitive enhancing and antioxidant effects of tetrahydroxystilbene glucoside in Aβ1-42-induced neurodegeneration in mice. J Integr Neurosci 17:355–65.
  • Yang Z, Ge C, Liu J, et al. (2015). Destruction of amyloid fibrils by graphene through penetration and extraction of peptides. Nanoscale 7:18725–37.
  • Ye X, Sun X, Starovoytov V, et al. (2015). Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains. Hum Mol Genet 24:2938–51.
  • Yoon J, Yang K, Kim D, et al. (2015). Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Biomaterials 73:243–53.
  • Zhang S, Ren Y, Qiu J. (2018). Dauricine inhibits viability and induces cell cycle arrest and apoptosis via inhibiting the PI3K/Akt signaling pathway in renal cell carcinoma cells. Mol Med Rep 17:7403–8.
  • Zhang Y, Fei H, Guo J, et al. (2019). Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway. Oncol Lett 18:4403–14.
  • Zhou J, Meng L, Ye W, et al. (2018). A sensitive detection assay based on signal amplification technology for Alzheimer's disease's early biomarker in exosome. Anal Chim Acta 1022:124–30.
  • Zhou X, Qu Y, Zheng Z, et al. (2019). Novel dauricine derivatives suppress cancer via autophagy-dependent cell death. Bioorg Chem 83:450–60.
  • Ziegler-Waldkirch S, d'Errico P, Sauer J, et al. (2018). Seed-induced Aβ deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer's disease. EMBO J 37:167–82.